Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study

Jiesuck Park; Eue-Keun Choi; Kyungdo Han; You‐Jung Choi; So-Ryoung Lee; Myung‐Jin Cha; Jeehoon Kang; Kyung Woo Park; Seil Oh; Professor Gregory Lip

doi:10.1016/j.amjcard.2019.03.024

Back

Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study

Article 2019 en

Related publications

Article2020

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention

Jiesuck Park, Eue-Keun Choi, Kyungdo Han, Bongseong Kim, You‐Jung Choi, So-Ryoung Lee, Jeehoon Kang, Myung‐Jin Cha, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2021

Dual antithrombotic therapy on early clinical outcomes in patients with atrial fibrillation after percutaneous coronary intervention: a nationwide study in the era of NOAC

J Park, Jin‐Hyung Jung, Eue-Keun Choi, S W Lee, Soonil Kwon, S R Lee, Jeehoon Kang, Kyungdo Han, K W Park, Seil Oh, Professor Gregory Lip

Article2020

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention

M Mihajlović, M Marinković, Monika Kozieł, Nebojša Mujović, Professor Gregory Lip, Tatjana Potpara

Article2019

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

Jiesuck Park, Eue-Keun Choi, Kyungdo Han, You-jung Choi, Euijae Lee, Wonseok Choe, So-Ryoung Lee, Myung‐Jin Cha, Woo‐Hyun Lim, Jeehoon Kang, Kyung Woo Park, Seil Oh, Professor Gregory Lip

Article2017

Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Jonas Oldgren, Philippe Gabríel Steg, Stefan H. Hohnloser, Professor Gregory Lip, Stephen G. Ellis, Takeshi Kimura, Matias Nordaby, Jurriën M. ten Berg, Deepak L. Bhatt, Christopher P. Cannon, Eva Kleine

Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study

Discussion(0)

Related publications

Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention

Dual antithrombotic therapy on early clinical outcomes in patients with atrial fibrillation after percutaneous coronary intervention: a nationwide study in the era of NOAC

Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome and / or undergoing percutaneous coronary intervention

Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study

Subgroup Analysis From the RE-DUAL PCI Trial : Dual Antithrombotic Therapy With Dabigatran in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention